The construction of a pharmaceutical production plant in Morlaix. This is the project of the Morlais biotechnology company Hemarina, which currently employs around 20 people. Its cost? € 19 million over three years. This is why its creator, Dr Franck Zal, submitted a “Industry Recovery Plan” file, under the call for projects for strategic sectors “support for modernization investments”.
In a letter addressed to Prime Minister Jean Castex, on May 25, by Jean-Paul Vermot, mayor of Morlaix and president of Morlaix community, no less than 18 prominent Breton personalities, including a majority of elected representatives representing several political sensibilities ( President of the Region, deputies, senators), give him “unanimous and unreserved” support. Others have since joined them.
100 M € of investments and hundreds of jobs at stake
They describe Hemarina’s project, called HO2PE (Hemoglobin Oxygen-carrier for Patient Emergencies), which consists of “the industrialization of a technological platform 4.0 for an oxygen carrier for therapeutic purposes”. In other words, the large-scale manufacture of products using the M101 molecule, derived from hemoglobin purified from lugworms, with oxygenating properties.
They also specify that beyond the stakes of “industrial and health sovereignty of France in terms of the supply of novel therapeutic products for the treatment of certain pathologies”, this project is of capital importance, from a point of view. economic, for a Morlais territory put to the test in recent years: closures of Gad and Tilly-Sabco, announcement of the closure of site Hop! by 2023, difficulties of Brittany Ferries due to Brexit and the health crisis. The construction of this factory would constitute, in fact, “the first step of an ambitious investment plan of approximately 100 M € on several axes of research and development, and the creation of hundreds of jobs in Morlaix over the years. to come up “.
Support a professional editorial staff at the service of Brittany and the Bretons: subscribe from € 1 per month.